Intravenous busulfan before autologous stem cell transplantation in children with cancer

被引：0
|
作者：
Le Guyader, N. [1 ]
Landre, T. [1 ]
Haouy, S. [1 ]
Landman-Parker, J. [1 ]
Fasola, S. [1 ]
Auvrignon, A. [1 ]
Leverger, G. [1 ]
机构：
[1] Hop Armand Trousseau, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [1] Efficacy and toxicity of intravenous busulfan before hematopoietic stem cell transplantation in children
    Styczynski, Jan
    Debski, Robert
    Krenska, Anna
    Wysocki, Mariusz
    BONE MARROW TRANSPLANTATION, 2008, 42 : S126 - S126
  • [2] Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation
    Bartelink, Imke H.
    Bredius, Robert G. M.
    Belitser, Svetlana V.
    Suttorp, Marit M.
    Bierings, Marc
    Knibbe, Catherijne A. J.
    Egeler, Maarten
    Lankester, Arjan C.
    Egberts, Atoine C. G.
    Zwaveling, Juliette
    Boelens, Jaap Jan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 231 - 241
  • [3] Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation
    Ansari, Marc
    Theoret, Yves
    Rezgui, Mohamed Aziz
    Peters, Christina
    Mezziani, Samira
    Desjean, Catherine
    Vachon, Marie-France
    Champagne, Martin A.
    Duval, Michel
    Krajinovic, Maja
    Bittencourt, Henrique
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 93 - 99
  • [4] Association between busulfan exposure and outcome in children receiving intravenous busulfan before haematopoietic stem cell transplantation
    Ansari, M.
    Theoret, Y.
    Rezgui, M.
    Mezziani, S.
    Desjean, C.
    Vachon, M.
    Labuda, M.
    Champagne, M.
    Duval, M.
    Peters, C.
    Krajinovic, M.
    Bittencourt, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S40 - S41
  • [5] Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation
    Cremers, S
    Schoemaker, R
    Bredius, R
    den Hartigh, J
    Ball, L
    Twiss, I
    Vermeij, P
    Vossen, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 386 - 389
  • [6] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [7] Intravenous busulfan in paediatric haematopoietic stem cell transplantation
    Kuskonmaz, B.
    Unal, S.
    Akan, A.
    Cetin, N.
    Akyol, F.
    Cetin, M.
    Tezcan, I.
    Uckan, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S304 - S304
  • [8] Intravenous busulfan in children prior to haematological stem cell transplantation: a narrow therapeutic window
    Bartelink, I. H.
    Bredius, R. G. M.
    Egberts, A. C. G.
    Suttorp, M. M.
    Bierings, M.
    Belitser, S.
    Knibbe, C. A. J.
    Zwaveling, J.
    Boelens, J. J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S50 - S50
  • [9] Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children
    Okamoto, Yasuhiro
    Nagatoshi, Yoshihisa
    Kosaka, Yoshiyuki
    Kikuchi, Akira
    Kato, Shunichi
    Kigasawa, Hisato
    Horikoshi, Yasuo
    Oda, Megumi
    Kaneda, Makoto
    Mori, Tetsuya
    Mugishima, Hideo
    Tsuchida, Masahiro
    Taniguchi, Shuichi
    Kawano, Yoshifumi
    PEDIATRIC TRANSPLANTATION, 2014, 18 (03) : 294 - 301
  • [10] Pharmacokinetics and Safety of Intravenous Busulfan in Children with High Risk Neuroblastoma and Ewing Sarcoma Undergoing Autologous Stem Cell Transplantation using Busulfan based Conditioning Regimen
    Keidar, Hila Rosenfeld
    Efrati, Edna
    Kurnik, Daniel
    Edelman, Sabina
    Tal, Alina
    Broitman, Marcela
    Abu Rizk, Jawad
    Dvir, Rina
    Levin, Dror
    Manisterski, Michal
    Achituv, Sivan
    Elhasid, Ronit
    BONE MARROW TRANSPLANTATION, 2018, 53 : 286 - 286
12345